Following positive research findings , retatrutide, a new peptide therapy for treating type 2 diabetes , has secured official approval from Great Britain's Medicines and Regulatory Agency ( the Agency https://mattiezfrk855228.dm-blog.com/41533880/retatrutide-compound-peptide-british-green-light-and-access